Editas Medicine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
CEOGilmore O’Neill
CEOGilmore O’Neill
Employees246
Employees246
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees246
Employees246
EDIT Key Statistics
Market cap209.88M
Market cap209.88M
Price-Earnings ratio-0.90
Price-Earnings ratio-0.90
Dividend yield—
Dividend yield—
Average volume1.93M
Average volume1.93M
High today$2.24
High today$2.24
Low today$2.13
Low today$2.13
Open price$2.16
Open price$2.16
Volume2.72M
Volume2.72M
52 Week high$4.54
52 Week high$4.54
52 Week low$0.9101
52 Week low$0.9101
Stock Snapshot
As of today, Editas Medicine(EDIT) shares are valued at $2.18. The company's market cap stands at 209.88M, with a P/E ratio of -0.90.
As of 2026-01-07, Editas Medicine(EDIT) stock has fluctuated between $2.13 and $2.24. The current price stands at $2.18, placing the stock +2.3% above today's low and -2.7% off the high.
The Editas Medicine(EDIT)'s current trading volume is 2.72M, compared to an average daily volume of 1.93M.
In the last year, Editas Medicine(EDIT) shares hit a 52-week high of $4.54 and a 52-week low of $0.91.
In the last year, Editas Medicine(EDIT) shares hit a 52-week high of $4.54 and a 52-week low of $0.91.
Analyst ratings
47%
of 15 ratingsBuy
46.7%
Hold
40%
Sell
13.3%
People also own
Based on the portfolios of people who own EDIT. This list is generated using Robinhood data, and it’s not a recommendation.